KMT2A and acute lymphoblastic leukemia: HOXA9 is linked to impaired differentiation of hematopoietic precursor cells and is frequently activated in mixed-lineage leukemia (MLL)-related AML and ALL, T-cell acute lymphoblastic leukemia (T-ALL) and in Nup98-rearranged AML (reviewed in [102]).